Clinical Trials in Hong Kong, Hong Kong
60 recruiting
Showing 1–20 of 53 trials
Recruiting
Phase 3
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-Negative Breast Carcinoma+2 more
Olema Pharmaceuticals, Inc.1,000 enrolled150 locationsNCT07085767
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263
Recruiting
Screening for Lung Cancer in Subjects With Family History of Lung Cancer
Lung Cancer
The University of Hong Kong1,520 enrolled1 locationNCT05762731
Recruiting
Phase 3
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Non-small Cell Lung CancerAdvanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.480 enrolled74 locationsNCT07185997
Recruiting
Proprioceptive Deficits in Degenerative Cervical Myelopathy
Cervical Myelopathy
The University of Hong Kong100 enrolled1 locationNCT05183971
Recruiting
Phase 2
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Novartis Pharmaceuticals240 enrolled103 locationsNCT05268289
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled60 locationsNCT07102628
Recruiting
Not Applicable
Evaluating the Effectiveness of Interventions to Reduce Loneliness in Chinese Young Adults
Loneliness
Education University of Hong Kong100 enrolled1 locationNCT07543653
Recruiting
Phase 3
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled96 locationsNCT06813911
Recruiting
Not Applicable
Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer
Pain CancerPancreatic Cancer Non-resectableTumor Pancreas
Chinese University of Hong Kong94 enrolled1 locationNCT06160323
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Not Applicable
Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment
Cognitive Functions
City University of Hong Kong110 enrolled1 locationNCT07372066
Recruiting
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
Tuberculosis
Chinese University of Hong Kong85 enrolled2 locationsNCT07170735
Recruiting
Phase 1Phase 2
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more
Dren Bio200 enrolled37 locationsNCT05475925
Recruiting
Not Applicable
Enhancing Physical Reserve to Promote Resilience in Physically Frail Older Adults
Frailty at Older Adults
The Hong Kong Polytechnic University224 enrolled1 locationNCT07513701
Recruiting
Not Applicable
rTMS Treatment of Spasticity in Children With Cerebral Palsy/ Hemiplegia Due to ABI - a RCT
CP (Cerebral Palsy)
The University of Hong Kong20 enrolled1 locationNCT06128746
Recruiting
Not Applicable
Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness
Depression, Unipolar
Chinese University of Hong Kong90 enrolled1 locationNCT06973759
Recruiting
Developing a Methodological Framework and a Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines
Herb-drug Interactions
Chinese University of Hong Kong40 enrolled1 locationNCT07248826
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-Negative Breast Carcinoma+2 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Not Applicable
Digital-supported Orofacial Myofunctional Therapy in OSA
Obstructive Sleep Apnea (OSA)
Hong Kong Metropolitan University60 enrolled1 locationNCT07292922